1019 related articles for article (PubMed ID: 19164362)
1. ST-segment depression as a risk factor in hypertrophic cardiomyopathy.
Haghjoo M; Mohammadzadeh S; Taherpour M; Faghfurian B; Fazelifar AF; Alizadeh A; Rad MA; Sadr-Ameli MA
Europace; 2009 May; 11(5):643-9. PubMed ID: 19164362
[TBL] [Abstract][Full Text] [Related]
2. Implantable cardioverter-defibrillators in hypertrophic cardiomyopathy.
Vieira AP; Adragão PP; Santos KR; Morgado FB; Cavaco DM; Rossi R; Abecasis M; Neves JP; Bonhosrst D; Gomes JL; Gomes RS
Rev Port Cardiol; 2005 Mar; 24(3):407-15. PubMed ID: 15929624
[TBL] [Abstract][Full Text] [Related]
3. Spectrum and prognostic significance of arrhythmias on ambulatory Holter electrocardiogram in hypertrophic cardiomyopathy.
Adabag AS; Casey SA; Kuskowski MA; Zenovich AG; Maron BJ
J Am Coll Cardiol; 2005 Mar; 45(5):697-704. PubMed ID: 15734613
[TBL] [Abstract][Full Text] [Related]
4. [The implantable cardioverter-defibrillator and hypertrophic cardiomyopathy. Experience at three centers].
Marín F; Gimeno JR; Payá E; García-Alberola A; Pérez-Alvarez L; Fernández X; de la Morena G; Sogorb F; Castro-Beiras A; Valdés M; Martínez JG; Monserrat L
Rev Esp Cardiol; 2006 Jun; 59(6):537-44. PubMed ID: 16790196
[TBL] [Abstract][Full Text] [Related]
5. Predictors of syncope in patients with hypertrophic cardiomyopathy.
Haghjoo M; Faghfurian B; Taherpour M; Fazelifar AF; Mohammadzadeh S; Alizadeh A; Sadr-Ameli MA
Pacing Clin Electrophysiol; 2009 May; 32(5):642-7. PubMed ID: 19422586
[TBL] [Abstract][Full Text] [Related]
6. Outcome of patients with hypertrophic cardiomyopathy and a normal electrocardiogram.
McLeod CJ; Ackerman MJ; Nishimura RA; Tajik AJ; Gersh BJ; Ommen SR
J Am Coll Cardiol; 2009 Jul; 54(3):229-33. PubMed ID: 19589435
[TBL] [Abstract][Full Text] [Related]
7. Implantable cardioverter-defibrillators in patients with hypertrophic cardiomyopathy -- dilemmas and difficulties.
Przybylski A; Małecka L; Pytkowski M; Chojnowska L; Lewandowski M; Sterliński M; Maciag A; Ruzyłło W; Szwed H
Kardiol Pol; 2005 Oct; 63(4):391-7; discussion 398. PubMed ID: 16273479
[TBL] [Abstract][Full Text] [Related]
8. Device complications and inappropriate implantable cardioverter defibrillator shocks in patients with hypertrophic cardiomyopathy.
Lin G; Nishimura RA; Gersh BJ; Phil D; Ommen SR; Ackerman MJ; Brady PA
Heart; 2009 May; 95(9):709-14. PubMed ID: 19282314
[TBL] [Abstract][Full Text] [Related]
9. [The relationship between QT dispersion and risk factors of sudden death in hypertrophic cardiomyopathy].
Göktekin O; Ritsushi K; Matsumoto K; Hiroshi M
Anadolu Kardiyol Derg; 2002 Sep; 2(3):226-30. PubMed ID: 12223331
[TBL] [Abstract][Full Text] [Related]
10. Relation of 12-lead electrocardiogram patterns to implanted defibrillator-terminated ventricular tachyarrhythmias in hypertrophic cardiomyopathy.
Sherrid MV; Cotiga D; Hart D; Ehlert F; Haas TS; Shen WK; Link MS; Estes NA; Epstein AE; Semsarian C; Daubert JP; Winters SL; Giudici MC; Maron BJ
Am J Cardiol; 2009 Dec; 104(12):1722-6. PubMed ID: 19962483
[TBL] [Abstract][Full Text] [Related]
11. Implantable defibrillators and prevention of sudden death in hypertrophic cardiomyopathy.
Maron BJ; Spirito P
J Cardiovasc Electrophysiol; 2008 Oct; 19(10):1118-26. PubMed ID: 18384577
[TBL] [Abstract][Full Text] [Related]
12. [Evaluation of the risk of sudden death in hypertrophic cardiomyopathy].
Sadoul N; de Chillou C; Aliot E; McKenna WJ
Arch Mal Coeur Vaiss; 1999 Apr; 92 Spec No 1():65-73. PubMed ID: 10326160
[TBL] [Abstract][Full Text] [Related]
13. The value of changes in QRS width and in ST-T segment during exercise test in hypertrophic cardiomyopathy for identification of associated coronary artery disease.
Cantor A; Yosefy C; Potekhin M; Ilia R; Keren A
Int J Cardiol; 2006 Sep; 112(1):99-104. PubMed ID: 16356568
[TBL] [Abstract][Full Text] [Related]
14. Implantable cardioverter-defibrillator in patients with hypertrophic cardiomyopathy: efficacy and complications of the therapy in long-term follow-up.
Syska P; Przybylski A; Chojnowska L; Lewandowski M; Sterliński M; Maciag A; Gepner K; Pytkowski M; Kowalik I; Maczyńska-Mazuruk R; Ruzyłło W; Szwed H
J Cardiovasc Electrophysiol; 2010 Aug; 21(8):883-9. PubMed ID: 20132378
[TBL] [Abstract][Full Text] [Related]
15. Hypertrophic cardiomyopathy in childhood and adolescence - strategies to prevent sudden death.
Ostman-Smith I
Fundam Clin Pharmacol; 2010 Oct; 24(5):637-52. PubMed ID: 20727015
[TBL] [Abstract][Full Text] [Related]
16. Noninvasive arrhythmia risk stratification in idiopathic dilated cardiomyopathy: results of the Marburg Cardiomyopathy Study.
Grimm W; Christ M; Bach J; Müller HH; Maisch B
Circulation; 2003 Dec; 108(23):2883-91. PubMed ID: 14623812
[TBL] [Abstract][Full Text] [Related]
17. Value of convex-type ST-segment elevation and abnormal Q waves for electrocardiographic-based identification of left ventricular remodeling in hypertrophic cardiomyopathy.
Furuki M; Kawai H; Onishi T; Hirata K
Kobe J Med Sci; 2009 Jun; 55(1):E16-29. PubMed ID: 19628972
[TBL] [Abstract][Full Text] [Related]
18. Risk factors and mode of death in isolated hypertrophic cardiomyopathy in children.
Decker JA; Rossano JW; Smith EO; Cannon B; Clunie SK; Gates C; Jefferies JL; Kim JJ; Price JF; Dreyer WJ; Towbin JA; Denfield SW
J Am Coll Cardiol; 2009 Jul; 54(3):250-4. PubMed ID: 19589438
[TBL] [Abstract][Full Text] [Related]
19. Characteristics and clinical significance of late gadolinium enhancement by contrast-enhanced magnetic resonance imaging in patients with hypertrophic cardiomyopathy.
Rubinshtein R; Glockner JF; Ommen SR; Araoz PA; Ackerman MJ; Sorajja P; Bos JM; Tajik AJ; Valeti US; Nishimura RA; Gersh BJ
Circ Heart Fail; 2010 Jan; 3(1):51-8. PubMed ID: 19850699
[TBL] [Abstract][Full Text] [Related]
20. Syncope and risk of sudden death in hypertrophic cardiomyopathy.
Spirito P; Autore C; Rapezzi C; Bernabò P; Badagliacca R; Maron MS; Bongioanni S; Coccolo F; Estes NA; Barillà CS; Biagini E; Quarta G; Conte MR; Bruzzi P; Maron BJ
Circulation; 2009 Apr; 119(13):1703-10. PubMed ID: 19307481
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
